Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal barrier function is a complex, multi-layered system that selectively allows the absorption of nutrients while preventing the entry of harmful substances into the bloodstream. It comprises the epithelial cell layer connected by tight junctions, the gut microbiota, and the gut-associated lymphoid tissue (GALT). Dysfunction of the intestinal barrier, often referred to as "leaky gut," is implicated in various diseases due to increased permeability and translocation of bacteria and toxins.
Varied, depending on the specific drug/intervention. Includes modulation of tight junction proteins, promotion of beneficial microbiota, reduction of inflammation, and direct barrier-protective effects.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal Barrier Function.